In Treatment of Male hypogonadism Male hypogonadism is a condition in which the body does not produce enough testosterone (male sex hormone). Asset 250mg Injection injections help improve the level of testosterone in your body. This helps in maintaining better sex life, improve overall physical appearance, gives good mood and boost overall confidence. Asset 250mg Injection also helps in muscle building and development of bones. This treatment has few side effects so it is advisable to always take the injection under a doctor’s supervision only. You should continue taking it as long as it is prescribed even if you feel better.
Caution is advised when consuming alcohol with Asset 250mg Injection. Please consult your doctor.
Asset 250mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Asset 250mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Asset 250mg Injection is not indicated for use in women.
Asset 250mg Injection does not usually affect your ability to drive.
Asset 250mg Injection is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Asset 250mg Injection is not advisable in patients with severe kidney disease.
Asset 250mg Injection is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor. Use of Asset 250mg Injection is not advisable in patients with severe liver disease.
If you miss a dose of Asset 250mg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Ind Swift Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jagsonpal Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Scott Edil Pharmacia Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mac Millon Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Meditech Pharma World || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Shree Venkatesh International Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Care Formulations || ₹14.5/tablet (25% cheaper)